Table 3.
Effect Sizes for the Comparisons of Study Sample Groups by SF-36 Physical and Mental Component Summary Scoresa
Scale | General Populationb | Diabetesc | Hypertensionc | Recent Myocardial Infarctionc | Congestive Heart Failurec | Depressionc |
Physical component summary score | ||||||
GAD (n = 128) | 0.50 | –0.29 | –0.05 | –0.20 | –0.85 | 0.00 |
GAD, no Axis I (n = 28) | 0.13 | –0.65 | –0.41 | –0.61 | −1.20 | –0.32 |
GAD, no medical illnesses (n = 80) | 0.49 | –0.31 | –0.07 | –0.23 | –0.88 | –0.01 |
GAD, no Axis I or medical illnesses (n = 20) | 0.38 | –0.42 | –0.17 | –0.35 | –0.98 | –0.10 |
Mental component summary score | ||||||
GAD (n = 128) | 1.48 | 1.71 | 1.78 | 1.72 | 1.39 | –0.03 |
GAD, no Axis I (n = 28) | 1.07 | 1.31 | 1.38 | 1.42 | 1.01 | –0.37 |
GAD, no medical illnesses (n = 80) | 1.49 | 1.75 | 1.83 | 1.83 | 1.42 | –0.02 |
GAD, no Axis I or medical illnesses (n = 20) | 1.02 | 1.27 | 1.34 | 1.43 | 0.97 | –0.41 |
Effect size calculation: (mean of comparison group – mean of GAD group) ÷ pooled SD. Positive effect sizes indicate worse functioning in the GAD group than in the comparison group.
General population scores are from the 1990 National Survey of Functional Health Status.32
Comparison groups are samples of individuals with select major medical illnesses from the Medical Outcomes Study.31
Abbreviations: GAD = generalized anxiety disorder, SF-36 = Medical Outcomes Study 36-item Short-Form Health Survey.